Exacerbation of psoriasis due to interferon-α treatment of chronic active hepatitis

M. J. Georgetson; J. C. Yarze; A. T. Lalos; G. F. Webster; P. Martin

Exacerbation of psoriasis due to interferon-α treatment of chronic active hepatitis

M. J. Georgetson, J. C. Yarze, A. T. Lalos, G. F. Webster, P. Martin

Research output: Contribution to journal › Article › peer-review

Abstract

Interferon-α is an immune modulating drug which is indicated for the treatment of chronic viral hepatitis B and C. Several previous reports have suggested an association between treatment of patients with interferon-α and the development or exacerbation of autoimmune diseases. We report two patients with chronic viral hepatitis in whom treatment with interferon-α was associated with dramatic worsening of previously diagnosed psoriasis, necessitating discontinuation of the drug.

Original language	English (US)
Pages (from-to)	1756-1758
Number of pages	3
Journal	American Journal of Gastroenterology
Volume	88
Issue number	10
State	Published - Jan 1 1993
Externally published	Yes

ASJC Scopus subject areas

Hepatology
Gastroenterology

UN SDGs

This output contributes to the following Sustainable Development Goal(s)

Fingerprint Dive into the research topics of 'Exacerbation of psoriasis due to interferon-α treatment of chronic active hepatitis'. Together they form a unique fingerprint.

Cite this

@article{0624cca5a16d477dbd7afb0ad7e4a73e,

title = "Exacerbation of psoriasis due to interferon-α treatment of chronic active hepatitis",

abstract = "Interferon-α is an immune modulating drug which is indicated for the treatment of chronic viral hepatitis B and C. Several previous reports have suggested an association between treatment of patients with interferon-α and the development or exacerbation of autoimmune diseases. We report two patients with chronic viral hepatitis in whom treatment with interferon-α was associated with dramatic worsening of previously diagnosed psoriasis, necessitating discontinuation of the drug.",

author = "Georgetson, {M. J.} and Yarze, {J. C.} and Lalos, {A. T.} and Webster, {G. F.} and P. Martin",

year = "1993",

month = jan,

day = "1",

language = "English (US)",

volume = "88",

pages = "1756--1758",

journal = "American Journal of Gastroenterology",

issn = "0002-9270",

publisher = "Nature Publishing Group",

number = "10",

}

TY - JOUR

T1 - Exacerbation of psoriasis due to interferon-α treatment of chronic active hepatitis

AU - Georgetson, M. J.

AU - Yarze, J. C.

AU - Lalos, A. T.

AU - Webster, G. F.

AU - Martin, P.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Interferon-α is an immune modulating drug which is indicated for the treatment of chronic viral hepatitis B and C. Several previous reports have suggested an association between treatment of patients with interferon-α and the development or exacerbation of autoimmune diseases. We report two patients with chronic viral hepatitis in whom treatment with interferon-α was associated with dramatic worsening of previously diagnosed psoriasis, necessitating discontinuation of the drug.

AB - Interferon-α is an immune modulating drug which is indicated for the treatment of chronic viral hepatitis B and C. Several previous reports have suggested an association between treatment of patients with interferon-α and the development or exacerbation of autoimmune diseases. We report two patients with chronic viral hepatitis in whom treatment with interferon-α was associated with dramatic worsening of previously diagnosed psoriasis, necessitating discontinuation of the drug.

UR - http://www.scopus.com/inward/record.url?scp=0027370219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027370219&partnerID=8YFLogxK

M3 - Article

C2 - 8213720

AN - SCOPUS:0027370219

VL - 88

SP - 1756

EP - 1758

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 10

ER -

Exacerbation of psoriasis due to interferon-α treatment of chronic active hepatitis

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Cite this